April 2, 2013
President Barack Obama today unveiled a $100 million public-private initiative to map the brain to gain greater insight on how we think, learn and remember and to better understand and treat diseases ranging from autism to schizophrenia.
April 1, 2013
Every Sunday, Pastor Arelious Walker stands at the pulpit at True Hope Church in Bayview and issues the same challenge to his congregation: Walk with me. He’s not speaking in religious terms.
March 22, 2013
The Li Ka Shing Foundation has pledged $2 million to support UC San Francisco’s efforts to advance precision medicine, an emerging field aimed at revolutionizing medical research and patient care.
March 21, 2013
An innovative project to develop a potential therapy to treat a wide range of cancers has won a major UC San Francisco award that aims to drive promising early-stage research through the complex process of translating ideas into patient benefit.
March 18, 2013
Screening for breast cancer every two years appears just as beneficial as yearly mammograms for women ages 50 to 74, with significantly fewer "false positives" - even for women whose breasts are dense or who use hormone therapy for menopause.
March 18, 2013
The American Cancer Society will pay tribute to Laura Esserman, MD, MBA, an internationally known leader in the field of breast cancer care and research.
March 15, 2013
As an undergrad and then a graduate student studying infectious disease and genetics, post-doctoral researcher Gundula Min-Oo, PhD, never imagined she'd find herself in the field of cancer research.
March 13, 2013
The immune system's T cells, while coordinating responses to diseases and vaccines, act like honey bees sharing information about the best honey sources, according to a new study by scientists at UC San Francisco.
March 12, 2013
UC San Francisco's School of Medicine ranked fourth nationwide in both research and primary care education this year, according to a new survey conducted by U.S. News & World Report.
March 11, 2013
Improving technologies are rapidly cutting the cost of whole genome sequencing, a process that reveals the complete library of a patient’s genetic information. Indeed, the era of the $1,000 genome — a catchphrase for the test’s relative affordability — appears imminent.